SCHEMBL6465230

SCHEMBL6465230

CCCCCCC(Br)CC(=O)O

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GPR84 Q9NQS5 11/20 0.62
PPARD Q03181 7/20 0.59
LCK P06239 1/20 0.59
ZDHHC20 Q5W0Z9 1/20 0.59
ZDHHC2 Q9UIJ5 1/20 0.59
FFAR1 O14842 3/20 0.50
FFAR4 Q5NUL3 2/20 0.50
ZDHHC7 Q9NXF8 1/20 0.48
MAPT P10636 1/20 0.48
PPARG P37231 6/20 0.46
PPARA Q07869 6/20 0.46
HDAC11 Q96DB2 5/20 0.46
TSHR P16473 4/20 0.46
ALDH1A1 P00352 2/20 0.46
TLR2 O60603 2/20 0.46
TDP1 Q9NUW8 2/20 0.46
FABP4 P15090 2/20 0.46
PTPN1 P18031 2/20 0.46
SLC22A6 Q4U2R8 1/20 0.46
SLC22A8 Q8TCC7 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL338175 1.00 GPR84 (0.62) GPR84PPARDLCKZDHHC20ZDHHC2
SCHEMBL6462164 1.00 GPR84 (0.62) GPR84PPARDLCKZDHHC20ZDHHC2
SCHEMBL366545 1.00 GPR84 (0.62) GPR84PPARDLCKZDHHC20ZDHHC2
SCHEMBL5550749 1.00 GPR84 (0.62) GPR84PPARDLCKZDHHC20ZDHHC2
SCHEMBL27709256 1.00 GPR84 (0.62) GPR84PPARDLCKZDHHC20ZDHHC2
SCHEMBL23829862 1.00 GPR84 (0.62) GPR84PPARDLCKZDHHC20ZDHHC2
SCHEMBL6460857 1.00 GPR84 (0.62) GPR84PPARDLCKZDHHC20ZDHHC2
SCHEMBL6463034 0.98 GPR84 (0.59) GPR84PPARDLCKZDHHC20ZDHHC2
SCHEMBL6464981 0.91 GPR84 (0.50) GPR84PPARDLCKZDHHC20ZDHHC2
SCHEMBL6464903 0.83 KDM4C (0.43) GPR84PPARDLCKZDHHC20ZDHHC2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210289794-A1 COMPOSITIONS AND RELATED METHODS FOR AGRICULTURE FLAGSHIP PIONEERING INNOVATIONS V, INC. 2021-09-23 US disclosed
US-6903233-B2 Process for producing optically active 3-halogenocarboxylic acid ester and 3-azidocarboxylic acid ester TAKASAGO INTERNATIONAL CORPORATION (JP) 2005-06-07 US disclosed
US-20030225301-A1 Process for producing optically active 3-halogenocarboxylic acid ester and 3-azidocarboxylic acid ester TAKASAGO INTERNATIONAL CORPORATION (JP) 2003-12-04 US disclosed
EP-1344763-A1 Process for producing optically active 3-halogenocarboxylic acid esters and 3-azide-carboxylic acid esters Takasago International Corporation (JP) 2003-09-17 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030225301-A1 Process for producing optically active 3-halogenocarboxylic acid ester and 3-azidocarboxylic acid ester HDHD5, APEH, AOC3 GPR84 3209/4885PPARD 3193/4885LCK 3355/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.